Lifeward Ltd. LFWD 深 滬
等待開盤 04-02 09:30:00 美东时间
6.80
+0.170
+2.56%
華盛通- 最 高6.80
- 今 開6.66
- 成交量 3813股
- 最 低 6.63
- 昨 收 6.63
- 總市值 2573.59万
- 52周最高 18.60
- 市盈率 靜 --
- 換手率 0.10%
- 52周最低 4.20
- 委 比 -60.00%
- 總股本 378.47万
- 歷史最高 91782.60
- 量 比 0.43
- 振 幅 2.56%
- 歷史最低 4.20
- 每 手 1
- 風險率 3.77%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lifeward Restores Nasdaq Compliance With Audit Committee Changes
An update from Lifeward ( ($LFWD) ) is now available. Lifeward Ltd. had previou...
03-31 23:29
Lifeward Closes The Strategic Partnership Agreement With Oramed Pharmaceuticals
Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed
03-26 04:17
Lifeward Successfully Closes on Strategic Partnership with Oramed
Lifeward Ltd. announced the closure of its strategic partnership with Oramed Pharmaceuticals Inc., acquiring Oramed's POD™ technology and securing up to $47 million in capital, with $10 million accessed. The partnership aims to diversify Lifeward's biomedical portfolio and enhance profitability, supporting its mission to innovate for individuals with physical limitations.
03-25 20:10
Lifeward Faces Nasdaq Audit Committee Compliance Challenge
The latest announcement is out from Lifeward ( ($LFWD) ). On March 17, 2026, Li...
03-21 05:10
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
HC Wainwright & Co. Maintains Buy on Lifeward, Raises Price Target to $10
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Lifeward (NASDAQ:LFWD) with a Buy and raises the price target from $4.5 to $10.
03-19 20:25
Lifeward shares are trading lower after the company reported mixed Q4 financial results.
Lifeward shares are trading lower after the company reported mixed Q4 financial...
03-19 00:30
Lifeward Q4 Adj. EPS $(2.85) Misses $(1.08) Estimate, Sales $5.081M Miss $7.861M Estimate
Lifeward (NASDAQ:LFWD) reported quarterly losses of $(2.85) per share which missed the analyst consensus estimate of $(1.08) by 163.89 percent. This is a 37.5 percent increase over losses of $(4.56) per share from the
03-18 20:04
Earnings Scheduled For March 18, 2026
Companies Reporting Before The Bell • SailPoint (NASDAQ:SAIL) is estimated to r...
03-18 19:11
Lifeward Ltd. Held Shareholder Meeting
Lifeward Ltd. Held Shareholder Meeting Lifeward Ltd. held an Extraordinary General Meeting of Shareholders on March 12, 2026. Shareholders approved the issuance of ordinary shares in connection with the Oratech Pharma acquisition and related financings, approved the election of two directors effecti
03-13 20:17
